|
English
|
正體中文
|
简体中文
|
2830311
|
|
???header.visitor??? :
32534162
???header.onlineuser??? :
1115
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"ryoo b y"???jsp.browse.items-by-author.description???
Showing items 31-32 of 32 (2 Page(s) Totally)
<< < 1 2
View [10|25|50] records per page
| 國立成功大學 |
2015-06-01 |
Combined analysis of two randomised Phase II trials comparing the efficacy and safety of nintedanib versus sorafenib in Caucasian and Asian patients with advanced hepatocellular carcinoma
|
Palmer, D.; Meyer, T.; Chao, Y.; Deptala, A.; Fartoux, L.; Feng, Y. -H.; Graham, J.; Lin, D. -Y.; Ma, Y. T.; Peck-Radosavljevic, M.; Ross, P.; Ryoo, B. -Y.; Yen, C. -J.; Hocke, J.; Vlassak, S.; Wenz, A.; Loembe, A. -B.; Cheng, A. -L. |
| 國立成功大學 |
2013-09 |
Efficacy and safety of nintedanib vs sorafenib in Asian patients with advanced hepatocellular carcinoma (HCC): A randomised Phase II trial
|
Yen, C.;Kim, T. Y.;Feng, Y. H.;Chao, Y.;Lin, D. Y.;Studeny, M.;Hocke, J.;Huang, D. C. L.;Ryoo, B. Y.;Cheng, A. L. |
Showing items 31-32 of 32 (2 Page(s) Totally)
<< < 1 2
View [10|25|50] records per page
|
